Tissue and Serum miRNA Profile in Locally Advanced Breast Cancer (LABC) in Response to Neo-Adjuvant Chemotherapy (NAC) Treatment.

Using miR-16 as normalization control, 3 significantly up-regulated miRNAs (miR-122, miR-222 and miR-223) and 1 significantly down-regulated miRNA (miR-21) in serum in HCC patients

Our microarray- based analysis of miRNA expression in mice cerebral cortex after TBI revealed that some miRNAs such as miR-21, miR-92a, miR- 874, miR-138, let-7c, and miR-124 could

As fold changes of upregulated microRNAs were greatly higher than that of the downregulated ones, the levels of the differentially expressed miR-3162-5p, miR- 4484, and miR-1229-5p

The serum levels of miR-3939 and miR-1910-3p differed significantly between the two groups in the screening stage; however, quantitative real-time polymerase chain reaction did

The aim of this study was to analyze the expression levels of the miRNAs miR- 146a, miR-155, and miR-326 in PBMC from T1D and healthy patients, and to estimate their possible

The results showed that the serum relative levels of only 3 miRNAs (miR-34a-5p, miR-221-3p and let-7d-3p) in MDD patients were obviously higher than these in control patients, and

The inclusion of patients with benign breast tumors enabled the observation that miR-148b, miR-652 and miR-801 levels are even elevated in the plasma of women with benign tumors

It also suggested that miR-100 does not affect the expressions of E-cadherin and Vimentin during the EMT, since E-cadherin and Vimentin were not target genes of miR-100 in all the